Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Acta Anaesthesiol Scand ; 61(7): 758-766, 2017 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-28626981

RESUMO

BACKGROUND: The incidence of post-discharge nausea and vomiting (PDNV) after ambulatory anaesthesia using total intravenous anaesthesia with a risk-stratified anti-emetic approach is not well documented in the literature. In this study, we outline such an approach. The goal was to achieve an acceptably low rate of PDNV both immediately and the day after surgery. METHODS: With ethics committee approval, adult patients undergoing outpatient surgery received a Propofol-based general anaesthetic plus standardised PONV-prophylaxis corresponding to their Apfel risk-score (0-4); ondansetron (risk-score 2), additional dexamethasone (risk-score 3), and additional droperidol (risk-score 4). On post-operative days one and two, patients scored PDNV and pain (numeric rating scale (NRS); 0 = none at all; 10 = worst imaginable). On post-operative day two, patients indicated the level of interference of PDNV and/or pain with their quality of life. Data are descriptive (%) or mean. RESULTS: There were 222 patients included (age 43 years, 44% female, anaesthesia time 95 min). On the day of surgery, 69.4% of patients did not experience any nausea, 10.4% complained about severe (NRS > 6) nausea, 6.3% experienced vomiting or retching. On the first and second postoperative day, nausea was absent in 88.7% of patients and 97.3%, respectively. Quality of life was impacted (NRS ≥ 4) more by pain (32.8% of cases), than by PDNV (13.6%). CONCLUSION: Acceptably low rates of PDNV were achieved with the proposed standardised approach to PDNV prophylaxis. For almost 90% of patients, PDNV was not an issue the first day after surgery. Pain after discharge was a more common problem.


Assuntos
Procedimentos Cirúrgicos Ambulatórios , Anestesia Intravenosa , Antieméticos/uso terapêutico , Alta do Paciente , Náusea e Vômito Pós-Operatórios/epidemiologia , Propofol , Adulto , Anestésicos Intravenosos , Dexametasona/uso terapêutico , Droperidol/uso terapêutico , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Ondansetron/uso terapêutico , Náusea e Vômito Pós-Operatórios/prevenção & controle , Estudos Prospectivos , Índice de Gravidade de Doença , Suíça/epidemiologia
2.
BMC Anesthesiol ; 17(1): 39, 2017 03 08.
Artigo em Inglês | MEDLINE | ID: mdl-28270097

RESUMO

BACKGROUND: Aim of this study was to identify factors associated with patients using the internet to find information about their upcoming surgery in general, and more specifically about anaesthesia. METHODS: With Ethics committee approval, 1000 consecutive patients seen before elective surgery in the anaesthesia preoperative clinic of a Swiss Level 2 hospital were asked to complete a questionnaire. Primary outcome were patients using the internet to gather any medical information related to their upcoming hospital stay, secondary outcome patients using the internet to gather information regarding the upcoming anaesthesia. Multiple regression was performed to identify independent factors associated with internet use. RESULTS: Eighty-two percent of the patients (n = 815) participated. 97% of those were ASA physical status 1 or 2; 83% (n = 676) had experience with previous anaesthetics, 86% (n = 700) reported to use the internet in general. Overall, about one-third of the participants used the internet to learn more about their medical condition, 26% regarding their upcoming surgical procedure. Only 7% (n = 55) obtained information about the anaesthetic. In multivariate analyses, factors associated with internet use were generally doing so, and planned moderate compared to minor surgery; not using the internet was associated with previous anaesthetic experience. Of those who did not use the Internet to learn about their anaesthetic, 34% indicated that they would have visited a trusted website. CONCLUSION: Only few patients used the internet to obtain information about their upcoming procedure and the anaesthetic part played an even smaller role. However, many patients would have appreciated guidance to find trustworthy internet sites. TRIAL REGISTRATION: German Clinical Trials Register ( DRKS00005434 ; date of registration: 27th December 2013); date of enrolment of first patient: 1st August 2013; study retrospectively registered.


Assuntos
Anestésicos , Internet/estatística & dados numéricos , Conhecimento do Paciente sobre a Medicação/estatística & dados numéricos , Inquéritos e Questionários , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Suíça , Adulto Jovem
3.
BMC Anesthesiol ; 16(1): 105, 2016 10 24.
Artigo em Inglês | MEDLINE | ID: mdl-27776488

RESUMO

BACKGROUND: Midazolam is commonly used as a pre-anesthesia anxiolytic. It`s elimination may not be fast enough for short procedures. In orally premedicated patients we obtained midazolam plasma concentrations at the end of surgical procedures and compared those to concentrations at anesthesia induction. METHODS: The study was conducted prospectively with consent of the local ethics committee (Ethikkomission Kanton Thurgau, Switzerland) and carried out with written informed consent of each patient. Female patients aged 20 to 60 years undergoing elective procedures with general anesthesia were included, and were divided in two groups according to the planned surgical time: group S (<30 min) and group L (90-120 min), respectively. All patients received 7.5 mg Midazolam po as premedication. Blood samples were drawn at anesthesia induction, and at the end of surgery. Data were compared with t-test (independent samples; significance level p <0.05). RESULTS: Twenty-five patients per group were included. Four patients were excluded from analysis, since midazolam was not detectable in any samples. Time of premedication to the 1st blood sample was not statistically different between groups, neither were Midazolam plasma levels at this time point (p = 0.94). None of the patients from group L (n = 24), but five patients in group S (n = 22) did have a higher plasma level of Midazolam at the end of the case compared to the beginning. CONCLUSIONS: The elimination half-life of oral Midazolam can lead to higher plasma levels at the end of a short procedure compared to those at induction of anesthesia. TRIAL REGISTRATION: German Clinical Trials Register (Deutsches Register Klinischer Studien), DRKS00005429 ; date of registration 3rd January 2014.


Assuntos
Ansiolíticos/farmacocinética , Midazolam/farmacocinética , Pré-Medicação/métodos , Administração Oral , Adulto , Anestesia Geral/métodos , Ansiolíticos/administração & dosagem , Procedimentos Cirúrgicos Eletivos/métodos , Feminino , Meia-Vida , Humanos , Midazolam/administração & dosagem , Pessoa de Meia-Idade , Estudos Prospectivos , Suíça , Fatores de Tempo , Adulto Jovem
4.
BMC Anesthesiol ; 15: 184, 2015 Dec 18.
Artigo em Inglês | MEDLINE | ID: mdl-26680779

RESUMO

BACKGROUND: Delirium has become better studied, but is still only partially understood and significantly underestimated. There are some well-known risk factors, but little is known about the incidence of delirium in the diverse patient population of a post anesthesia care unit (PACU). The aim of this study was to investigate the presence of delirium using the Nursing Delirium Screening Scale (NU-DESC). METHODS: 1000 consecutive patients in the PACU were prospectively evaluated at the point when being ready to be transferred to the normal ward by the registered nurses of the PACU. RESULTS: The data of 1,000 patients was recorded. 242 of the patients (24.2%) were preoperatively classified as ASA I physical status, 664 patients (66.4%) as ASA II. A total of 43 patients (4.3%) presented with a delirium at the time point where they would have been transferred to the normal ward (138.4 ± 55.2 min after arrival in the PACU). 287 patients (28.7%) of the entire group were over the age of 70 years. Considering only this subgroup, delirium was diagnosed in 30 individuals (10.5%). CONCLUSIONS: Delirium screening with the NU-DESC, collected by nursing staff of a PACU is easily feasible and demonstrated a low incidence of delirium in the presented setting. TRIAL REGISTRATION: German Clinical Trials Register (Deutsches Register Klinischer Studien, www.drks.de ; DRKS 000005426 ; date of registration 4th December 2013).


Assuntos
Período de Recuperação da Anestesia , Anestesia/efeitos adversos , Delírio/induzido quimicamente , Delírio/diagnóstico , Complicações Pós-Operatórias/induzido quimicamente , Complicações Pós-Operatórias/diagnóstico , Delírio/enfermagem , Estudos de Viabilidade , Feminino , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Recursos Humanos de Enfermagem Hospitalar , Complicações Pós-Operatórias/enfermagem , Estudos Prospectivos , Fatores de Risco , Suíça
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA